XB7-40677-33226
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 913 / CA
- Registered
- 2022-07-30
- Relationship
- Child or adolescent in my care
- Guardian
- PEU-17692-38034
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-30
Registered in v-safe
-
2022-07-30
Dose 1 — Moderna
-
2022-07-31
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Fever · Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-08-01
-
2022-08-02
Survey response — days 1–6 daily, dose 1, under 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-08-03
Survey response — days 1–6 daily, dose 1, under 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2022-08-04
- 2022-08-05
- 2022-08-06
- 2022-08-15
- 2022-08-20
-
2022-08-27
Dose 2 — Moderna
- 2022-08-29
- 2022-08-31
- 2022-09-01
- 2022-09-02
- 2022-09-03
- 2022-09-10
- 2022-09-17
-
2022-09-24
Survey response — day 28, dose 2, under 3MedDRA: Roseola — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RoseolaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-24
Report sent to call center — day 28, dose 2, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-01
-
2022-10-08
Survey response — day 42, dose 2, under 3MedDRA: Irritability, Pyrexia — Feeling: GoodFree text: Fevers, fussinessMedDRA releases: 2024-11 · check-in free text available
- 2022-11-26
- 2023-02-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-30 | Moderna | No |
| 2 | 2022-08-27 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): No
Systemic reaction (other): No
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Roseola
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Fevers, fussiness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Irritability | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Roseola | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release